Cormorant Asset Management as of June 30, 2022
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 80 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Turning Point Therapeutics I | 14.1 | $187M | 2.5M | 75.25 | |
| Design Therapeutics (DSGN) | 5.8 | $77M | 5.5M | 14.00 | |
| Erasca (ERAS) | 4.4 | $59M | 11M | 5.57 | |
| Prometheus Biosciences | 4.3 | $57M | 2.0M | 28.23 | |
| Apellis Pharmaceuticals (APLS) | 3.2 | $43M | 950k | 45.22 | |
| Revolution Medicines (RVMD) | 2.9 | $39M | 2.0M | 19.49 | |
| Biomea Fusion (BMEA) | 2.9 | $38M | 3.2M | 11.98 | |
| Chemocentryx | 2.7 | $35M | 1.4M | 24.78 | |
| Altimmune Com New (ALT) | 2.7 | $35M | 3.0M | 11.70 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 2.5 | $33M | 450k | 74.27 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.3 | $31M | 6.1M | 5.09 | |
| Edgewise Therapeutics (EWTX) | 2.3 | $31M | 3.9M | 7.96 | |
| Avidity Biosciences Ord (RNA) | 2.2 | $29M | 2.0M | 14.53 | |
| Monte Rosa Therapeutics (GLUE) | 2.2 | $29M | 3.0M | 9.67 | |
| Arcellx Common Stock (ACLX) | 2.1 | $28M | 1.5M | 18.08 | |
| Tarsus Pharmaceuticals (TARS) | 2.1 | $27M | 1.9M | 14.60 | |
| Aerovate Therapeutics (AVTE) | 2.0 | $27M | 1.7M | 15.63 | |
| Biohaven Pharmaceutical Holding | 2.0 | $27M | 185k | 145.71 | |
| Adicet Bio (ACET) | 2.0 | $26M | 1.8M | 14.60 | |
| Pharvaris N V (PHVS) | 1.9 | $25M | 1.1M | 22.10 | |
| Forma Therapeutics Hldgs SHS | 1.7 | $22M | 3.2M | 6.89 | |
| Horizon Therapeutics Pub L SHS | 1.6 | $21M | 268k | 79.76 | |
| Tango Therapeutics (TNGX) | 1.5 | $20M | 4.5M | 4.53 | |
| Mirati Therapeutics | 1.5 | $20M | 300k | 67.13 | |
| Axonics Modulation Technolog (AXNX) | 1.4 | $18M | 322k | 56.67 | |
| Karuna Therapeutics Ord | 1.2 | $16M | 125k | 126.51 | |
| Cytokinetics Com New (CYTK) | 1.2 | $16M | 400k | 39.29 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $16M | 275k | 57.08 | |
| Vectivbio Hldg Ord Shs | 1.2 | $15M | 2.8M | 5.40 | |
| Greenlight Biosciencs Hlds P Common Stock | 1.2 | $15M | 7.0M | 2.19 | |
| Stoke Therapeutics (STOK) | 1.1 | $14M | 1.1M | 13.21 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.1 | $14M | 2.9M | 4.87 | |
| Bridgebio Pharma (BBIO) | 1.0 | $13M | 1.5M | 9.08 | |
| Rain Therapeutics | 1.0 | $13M | 2.3M | 5.56 | |
| Immuneering Corp Class A Com (IMRX) | 0.9 | $12M | 2.3M | 5.41 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $12M | 869k | 13.76 | |
| Springworks Therapeutics (SWTX) | 0.9 | $12M | 475k | 24.62 | |
| Atea Pharmaceuticals (AVIR) | 0.8 | $11M | 1.5M | 7.10 | |
| Verve Therapeutics (VERV) | 0.8 | $11M | 701k | 15.28 | |
| Miragen Therapeutics (VRDN) | 0.8 | $10M | 878k | 11.57 | |
| Kezar Life Sciences (KZR) | 0.8 | $9.9M | 1.2M | 8.27 | |
| Ventyx Biosciences (VTYX) | 0.7 | $9.5M | 781k | 12.23 | |
| Olema Pharmaceuticals (OLMA) | 0.6 | $8.5M | 2.1M | 4.07 | |
| Axsome Therapeutics (AXSM) | 0.6 | $7.9M | 205k | 38.30 | |
| Longboard Pharmaceuticals In (LBPH) | 0.5 | $7.0M | 2.3M | 3.09 | |
| Cogent Biosciences (COGT) | 0.5 | $6.8M | 750k | 9.02 | |
| Ambrx Biopharma Sponsored Ads | 0.5 | $6.6M | 2.5M | 2.65 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $6.1M | 608k | 9.98 | |
| Bioatla (BCAB) | 0.4 | $5.8M | 2.0M | 2.85 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $5.8M | 712k | 8.09 | |
| Celldex Therapeutics Com New (CLDX) | 0.4 | $5.4M | 200k | 26.96 | |
| Tyra Biosciences (TYRA) | 0.4 | $5.3M | 744k | 7.15 | |
| Talaris Therapeutics | 0.4 | $5.3M | 1.2M | 4.51 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $4.6M | 50k | 92.96 | |
| Pliant Therapeutics (PLRX) | 0.3 | $3.9M | 482k | 8.01 | |
| Akero Therapeutics (AKRO) | 0.3 | $3.8M | 404k | 9.45 | |
| Icosavax | 0.3 | $3.7M | 651k | 5.73 | |
| Eledon Pharmaceuticals (ELDN) | 0.2 | $3.2M | 1.3M | 2.44 | |
| Elevation Oncology (ELEV) | 0.2 | $2.8M | 2.0M | 1.40 | |
| Keros Therapeutics (KROS) | 0.2 | $2.8M | 100k | 27.63 | |
| Y Mabs Therapeutics (YMAB) | 0.2 | $2.3M | 150k | 15.13 | |
| Akouos | 0.1 | $1.9M | 395k | 4.69 | |
| Galecto (GLTO) | 0.1 | $1.8M | 1.0M | 1.73 | |
| Gossamer Bio (GOSS) | 0.1 | $1.7M | 198k | 8.37 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $1.6M | 669k | 2.38 | |
| Vigil Neuroscience (VIGL) | 0.1 | $1.6M | 617k | 2.58 | |
| Cabaletta Bio (CABA) | 0.1 | $1.2M | 1.2M | 1.06 | |
| Meiragtx Holdings (MGTX) | 0.1 | $1.1M | 150k | 7.57 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $1.1M | 392k | 2.83 | |
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $1.1M | 288k | 3.70 | |
| Harpoon Therapeutics | 0.1 | $1.0M | 541k | 1.91 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $1.0M | 50k | 20.30 | |
| Renovacor | 0.1 | $1.0M | 500k | 2.03 | |
| Gelesis Holdings (GLSH) | 0.1 | $970k | 626k | 1.55 | |
| Astria Therapeutics (ATXS) | 0.1 | $900k | 300k | 3.00 | |
| Atreca Cl A Com (BCEL) | 0.0 | $571k | 319k | 1.79 | |
| Graphite Bio | 0.0 | $549k | 200k | 2.75 | |
| Imv | 0.0 | $155k | 234k | 0.66 | |
| Orchard Therapeutics Ads | 0.0 | $150k | 257k | 0.58 | |
| X4 Pharmaceuticals (XFOR) | 0.0 | $100k | 104k | 0.96 |
